Ligand Announces Pricing of $400 Million Convertible Senior Notes Offering - Ligand Pharmaceuticals (NASDAQ:LGND)

Ligand Announces Pricing of $400 Million Convertible Senior Notes Offering - Ligand Pharmaceuticals (NASDAQ:LGND)

JUPITER, Fla., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) ("Ligand") announced today the pricing of $400.0 million aggregate principal amount of 0.75% convertible senior notes due 2030 (the "notes") in a private placement (the "offering") to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). Ligand als…